Cite
Sapin C, Tempest MJ, Gaughran F, et al. Aripiprazole Once-Monthly is a Cost-Effective Therapeutic Option in the Maintenance Treatment of Schizophrenia: Results from a Markov Model. Value Health. 2014;17(7):A457-8doi: 10.1016/j.jval.2014.08.1258.
Sapin, C., Tempest, M. J., Gaughran, F., Beillat, M., Robinson, P., & Treur, M. (2014). Aripiprazole Once-Monthly is a Cost-Effective Therapeutic Option in the Maintenance Treatment of Schizophrenia: Results from a Markov Model. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A457-8. https://doi.org/10.1016/j.jval.2014.08.1258
Sapin, C, et al. "Aripiprazole Once-Monthly is a Cost-Effective Therapeutic Option in the Maintenance Treatment of Schizophrenia: Results from a Markov Model." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A457-8. doi: https://doi.org/10.1016/j.jval.2014.08.1258
Sapin C, Tempest MJ, Gaughran F, Beillat M, Robinson P, Treur M. Aripiprazole Once-Monthly is a Cost-Effective Therapeutic Option in the Maintenance Treatment of Schizophrenia: Results from a Markov Model. Value Health. 2014 Nov;17(7):A457-8. doi: 10.1016/j.jval.2014.08.1258. Epub 2014 Oct 26. PMID: 27201270.
Copy
Download .nbib